'Grey Tsunami' Creates Surge in Physiotherapy Growth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
'Grey Tsunami' Creates Surge in Physiotherapy Growth

VANCOUVER, British Columbia, Aug. 12, 2014 (GLOBE NEWSWIRE) -- David Cole (54), a Seattle businessman, still plays competitive soccer and that is taking a toll on his body. "In the last three year years I've torn a quad muscle, a calf muscle and a tendon in my shoulder," explains Cole, "This has required multiple trips to the physiotherapist".

Aging athletes are a key part of the "Grey Tsunami" that is flowing into Rehab and Physiotherapy Clinics across the U.S. The $31 billion market is growing at an annual rate of 6.1%.

Agility Health (TSX-V:AHI) has carved out a profitable niche in this space, and the company has just announced a "transformative" deal which is expected to increase annual revenues from about $65 million to pro forma revenues exceeding $100 million. The current market cap of Agility ($40 million) has not factored in the significant anticipated revenue bump ($39 million) from the new acquisition.

The total acquisition consideration of $20.8 million cash is less than 5x the anticipated pro forma EBITDA of the entity and would expand Agility Health operations to more than 200 sites across 26 states with more than 1,800 employees providing services for approximately 2 million patient visits per year. The acquisition of the target will be immediately accretive to Agility's earnings.

"The target company complements a key area of strategic growth," stated Davidson, "It's a line of business that we are looking to further grow in, and to specialize in. We believe we can advance their existing client relationships for both company's benefit."

Agility Health currently operates 74 outpatient or onsite rehabilitation locations in 17 states. The company also contracts rehabilitative services to 41 hospitals and inpatient rehabilitation units, 36 nursing homes, long-term care facilities and other service locations in 9 states. The company also provides embedded services at manufacturing facilities for a plethora of Fortune 500 companies. Further, Agility has an orthotics company with an elite athlete client list.

"Our service offerings are diverse by design," stated Davidson, "In the US, each region is unique, with different micro-healthcare economies. Our diversity allows us to cross-sell, and it creates a strong defensive position if market conditions change. Our skill set and services are customizable to any regulatory environment or geographic location. The key is that we have developed proprietary software that ties it all together."

"Another area of strategic growth is outpatient clinic acquisitions and development," stated Agility Health CEO Steven N. Davidson in an exclusive interview with Financial Press, "We target clinic owners who have developed 2-5 clinics. Agility run outpatient clinics are free-standing, and we partner with clinics where Agility become a majority owner. It's a good niche that is still meaningful for companies of our scale, but too small for larger competitors."

Davidson explains that a typical owner of a rehab clinic is very passionate about being a clinician, and building their practice. Agility provides "the back office functions that they don't like to do, and typically not skilled at". Namely, human resources, accounting, technology, data management and compliance.

When Agility acquires clinical practices, the seller typically retains 20-30% equity, so they are incentivized on the backend. Sellers also have access to funds to monetize and further scale their business. "The real synergy comes when a clinic operator can say, "I know doctors in an under-served area, let's investigate the economics of starting a clinic there to address the market need."

"We have developed a high tech infrastructure designed for outpatient clinics and hospital departments," stated Davidson, "We can take time consuming tasks off their plate which allows them to be better practitioners, better businesspeople."

Agility also manages the technology practice management for hospital rehabilitation departments. The company presently has about 25 hospital clients that are transitioning to Agility's next generation of software that also contains a clinical database with 290,000 cases. "We are currently validating data that will help us predict how long somebody should typically be receiving therapy, based on a standardized set of clinical data collection embedded in our software," stated Davidson, "This will allow us to manage cases internally and also externally for insurance companies."

"Our sweet spot is deploying our technology and entrepreneurial skill set to a hospital that doesn't regard rehab as a core competency," stated Davidson. "Joint-venturing with a hospital is the perfect scenario for us. We are in discussions with various hospital systems right now, demonstrating to them how we can save money, streamline business, and increase their quality of care."

"Data means everything to all stakeholders and is key," confirms Davidson, "It is vital for clinicians to have the ability to validate effectiveness and patient satisfaction. Data-driven decision-making is where we see the future. Creating software to manage a clinical database is central to our vision."

There is a big push in the U.S. to transition patients out of the hospital as quickly as possible – creating more post-operative care. 'Evidence-based medicine' is in vogue and prompts the question: "What's the research behind a given therapy?" If you're a spine patient, should you be receiving acupuncture, surgery, chiropractic treatment or physiotherapy? What treatment modality provides the best value and results?

Davidson further explains that "Obamacare" supported initiatives are putting the money into the hands of institutions to manage the entire length of a patient case, from the time the patient sees a doctor for their condition, through to surgery and post-operative care.

"The 'grey tsunami' is a meaningful factor for Agility. As you get older, injury rates go up. Physiotherapy utilization is 3-5% a year for the general population and over 10% for a 65-year-old. Also, there are changing attitudes to physiotherapy, as patients are increasingly self-referring to a physiotherapist."

Agility Health is currently trading at $0.51 with a market cap of $41 million.

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

Agility Health Inc. 607 Dewey Avenue NW Suite 300 Grand Rapids, MI 49504 (800) 876-1041 (616) 356-5000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 15

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 16

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 13

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Guaranty Bancshares Sale Investigation by Top Legal Team

Updated Category News Views 145

Understanding the Sale of Guaranty Bancshares, Inc. The recent announcement regarding the proposed sale of Guaranty Bancshares, Inc. to Glacier Bancorp, Inc. has garnered significant attention. Shareholders will reportedly receive 1.0000 share of Glacier stock for each share they hold in Guaranty. This transaction raises important questions regarding its valuation and the...

Continue Reading
Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas

Updated Category News Views 147

Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas Ascenz Marorka, the smart shipping arm of GTT, has recently made strides by expanding its Real-Time Fleet Performance Monitoring Service to encompass the Americas. This strategic development follows the success of deployments in renowned maritime hubs, showcasing Ascenz Marorka's commitment to enhancing...

Continue Reading
Ares Management Expands Renewable Energy Footprint with New Acquisition

Updated Category News Views 334

Ares Management Expands Renewable Energy Footprint Recently, Ares Management Corporation (NYSE: ARES) announced a remarkable acquisition that underscores their commitment to renewable energy. A fund managed under the Ares Infrastructure Opportunities strategy has secured a 49% stake in a diverse energy asset portfolio valued at approximately $2.9 billion. This strategic...

Continue Reading
RLX Technology Set to Share Financial Insights This Quarter

Updated Category News Views 145

RLX Technology to Announce Third Quarter Financial Results Internationally recognized for its innovative approach, RLX Technology Inc. (NYSE: RLX) is gearing up to unveil its financial performance for the third quarter, which will end September 30, 2025. This announcement will occur just before the U.S. markets open on November 14, 2025. As a global leader in the e-vapor...

Continue Reading
Grok AI Gets Federal Approval: Key Insights for Musk and Trump

Updated Category News Views 302

Grok AI Federal Approval Marks a New Era The approval for Elon Musk's AI chatbot, Grok, to be utilized by all federal agencies represents a groundbreaking development in how artificial intelligence can enhance government operations. The General Services Administration (GSA) has granted this approval along with special provisions from Musk's AI company, xAI. Understanding...

Continue Reading